Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Allogene outlines plan for ~100 ALPHA3 sites by year end as FDA grants RMAT and Fast Track for cema-cel

We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Read the original at seekingalpha.com →

More in Health & Medicine

More from Wednesday 12 August →